NCT01771406

CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.

Effects of Continuous Positive Airway Pressure (CPAP) and Nebivolol Treatment on Arterial Blood Pressure and Endothelial Function in Hypertensive OSA Patients.

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to examine how effective CPAP treatment and treatment with nebivolol are respectively on reducing blood pressure and on endothelial dysfunction in patients suffering from obstructive sleep apnea and hypertension.

Conditions

• Hypertension
• Endothelial Dysfunction
• Obstructive Sleep Apnea

Interventions

Type	Name	Description
DRUG	Nebivolol	8 weeks of Nebivolol treatment (5mg/day)
DEVICE	Continuous positive airway pressure (CPAP)	8 weeks of CPAP treatment

Timeline

• Start date: 2013-02-01
• Primary completion: 2016-02-01
• Completion: 2016-02-01
• First posted: 2013-01-18
• Last updated: 2013-01-18

Locations

1 site across 1 country: Belgium